St. Jude Medical, Inc. (NYSE: STJ) announced results from two cardiovascular clinical trials presented at EuroPCR 2016. The studies, which ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE